
Vopril M 1mg/500mg Tablet SR
Marketer
Voopar Sciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Vopril M 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to complications such as renal impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is a component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, lightheadedness, headache, and tremors. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sweets, juice). Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Vopril M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vopril M 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vopril M 1mg/500mg Extended-Release Tablets with a meal.
Common Side effects of Vopril M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Vopril M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vopril M 1mg/500mg Extended-Release tablets should be administered with food.
How Vopril M 1mg/500mg Tablet SR works:
The extended-release tablet Vopril M (1mg/500mg) combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vopril M 1mg/500mg SR tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Vopril M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Vopril M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms appear.
KidneyCAUTION
Exercise caution when administering Vopril M 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Vopril M 1mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vopril M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; Vopril M 1mg/500mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Vopril M 1mg/500mg Tablet SR :
Should you forget to take a Vopril M 1mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vopril M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
